Your browser doesn't support javascript.
loading
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew, David; Devos, Nathalie; Lambert, Christophe; Brown, James R; Clarke, Stuart C; Kim, Viktoriya L; Magid-Slav, Michal; Miller, Bruce E; Ostridge, Kristoffer K; Patel, Ruchi; Sathe, Ganesh; Simola, Daniel F; Staples, Karl J; Sung, Ruby; Tal-Singer, Ruth; Tuck, Andrew C; Van Horn, Stephanie; Weynants, Vincent; Williams, Nicholas P; Devaster, Jeanne-Marie; Wilkinson, Tom M A.
Affiliation
  • Mayhew D; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Devos N; GSK Vaccines, Rixensart, Belgium.
  • Lambert C; GSK Vaccines, Rixensart, Belgium.
  • Brown JR; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Clarke SC; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
  • Kim VL; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.
  • Magid-Slav M; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.
  • Miller BE; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Ostridge KK; Respiratory Therapy Area Unit, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Patel R; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.
  • Sathe G; Target and Pathway Validation, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Simola DF; Target and Pathway Validation, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Staples KJ; Computational Biology, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Sung R; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
  • Tal-Singer R; Southampton NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK.
  • Tuck AC; Wessex Investigational Sciences Hub, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
  • Van Horn S; Respiratory Therapy Area Unit, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Weynants V; Respiratory Therapy Area Unit, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Williams NP; Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton, UK.
  • Devaster JM; Target and Pathway Validation, Target Sciences, GSK R&D, King of Prussia, Pennsylvania, USA.
  • Wilkinson TMA; GSK Vaccines, Rixensart, Belgium.
Thorax ; 73(5): 422-430, 2018 05.
Article in En | MEDLINE | ID: mdl-29386298
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Eosinophilia / Disease Progression / Pulmonary Disease, Chronic Obstructive / Microbiota / Lung Type of study: Observational_studies / Qualitative_research / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Thorax Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Eosinophilia / Disease Progression / Pulmonary Disease, Chronic Obstructive / Microbiota / Lung Type of study: Observational_studies / Qualitative_research / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Thorax Year: 2018 Document type: Article Affiliation country: Country of publication: